
- Volume 0 0
Ofloxacin Tablets
Teva Pharmaceuticals USA (North Wales, Pa)recently announced the introduction and availability ofOfloxacin Tablets. This product is AB-rated and is bioequivalentto Ortho-McNeil?s Floxin tablets. The productis prescribed to patients to reduce the development ofdrug-resistant bacteria and to maintain the effectivenessof this and other antibacterial drugs. Ofloxacin Tablets areindicated for the treatment of adults with mild-to-moderateinfections (unless otherwise indicated) caused bysusceptible strains of designated microorganisms. Theseinfections include chronic bronchitis, community-acquiredpneumonia, and acute pelvic inflammatory disease,among others. Ofloxacin Tablets 200, 300, and 400 mgare available in bottle sizes of 100. For more information,visit www.tevapharmusa.com.
Articles in this issue
almost 22 years ago
Interface Speeds Up Prescription Fillingalmost 22 years ago
New Technologies Top Surveyalmost 22 years ago
Partnership Addresses Packaging Solutionsalmost 22 years ago
PDX Software Gets High Marksalmost 22 years ago
Polar Powder Cold Pak with Magnetic Therapyalmost 22 years ago
Seal•ONalmost 22 years ago
SaltAire Sinus Reliefalmost 22 years ago
Zim's Crack Creme Hand Sanitizeralmost 22 years ago
CoroWise Plant Sterolsalmost 22 years ago
CulturelleNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

















































































































































































































